Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
David Bibbey, Dipl. Ac., LAc
David Bibbey has served on the Florida State Oriental Medical Association’s board of directors for a decade, including serving as FSOMA president from 2021-2023. He is currently chair of the association’s Legislative Committee. He also practices in Crystal River, Fla.; and is the CEO of Patient Data Protection, LLC, a HIPAA and ADA compliance company specializing in supporting small practices and sole providers with HIPAA Privacy & Security Rule technologies and ADA website accessibility.